Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis Chatelain

Showing results (121-130 of 136) with videos related to

Pageof 14
Sort By:
The New England Journal of Medicine|November 11, 2011
Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitisEric Nguyen-Khac, Thierry Thevenot, Marie-Astrid Piquet, et al.
Digestive Diseases and Sciences|September 24, 2016
Incidence, Clinical Presentation, and Associated Factors of Microscopic Colitis in Northern France: A Population-Based StudyMathurin Fumery, Mathieu Kohut, Corinne Gower-Rousseau, et al.
Molecular Cancer Research : MCR|July 22, 2010
BAD, a proapoptotic member of the BCL2 family, is a potential therapeutic target in hepatocellular carcinomaAntoine Galmiche, Zakaria Ezzoukhry, Catherine François, et al.
Clinical and Translational Gastroenterology|September 4, 2019
Long-Term Natural History of Microscopic Colitis: A Population-Based CohortJulien Loreau, Dana Duricova, Corinne Gower-Rousseau, et al.
Plos One|December 31, 2013
Identification of SLAMF3 (CD229) as an inhibitor of hepatocellular carcinoma cell proliferation and tumour progressionIngrid Marcq, Rémy Nyga, Flora Cartier, et al.
The Lancet. Gastroenterology & Hepatology|July 10, 2018
Non-invasive diagnosis of liver fibrosis in patients with alcohol-related liver disease by transient elastography: an individual patient data meta-analysisEric Nguyen-Khac, Maja Thiele, Cosmin Voican, et al.
Cell Biology and Toxicology|February 26, 2026
Chronic cadmium exposure promotes TRPM7-dependent acquisition of a myofibroblast-like phenotype in pancreatic stellate cellsMathilde Fourgeaud, Julie Auwercx, Alexis Lalot, et al.
Endocrine-Related Cancer|August 3, 2022
Second-line treatment and prognostic factors in neuroendocrine carcinoma: the RBNEC studyJulien Hadoux, Thomas Walter, Christina Kanaan, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2021
Prognostic factors of metastatic neuroendocrine carcinoma under first-line treatment with platinum etoposide with a focus on NEC score and Rb expression: Results from the multicentre RBNEC study of the Groupe d'Etude des Tumeurs Endocrines (GTE) and the ENDOCAN-RENATEN networkJulien Hadoux, Christina Kanaan, Alice Durand, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 4, 2014
Tumour size over 3 cm predicts poor short-term outcomes after major liver resection for hilar cholangiocarcinoma. By the HC-AFC-2009 groupJean Marc Regimbeau, David Fuks, Patrick Pessaux, et al.
Pageof 14

Showing results (121-130 of 136) with videos related to

Sort By:
Pageof 14
The New England Journal of Medicine|November 11, 2011
Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitisEric Nguyen-Khac, Thierry Thevenot, Marie-Astrid Piquet, et al.
Digestive Diseases and Sciences|September 24, 2016
Incidence, Clinical Presentation, and Associated Factors of Microscopic Colitis in Northern France: A Population-Based StudyMathurin Fumery, Mathieu Kohut, Corinne Gower-Rousseau, et al.
Molecular Cancer Research : MCR|July 22, 2010
BAD, a proapoptotic member of the BCL2 family, is a potential therapeutic target in hepatocellular carcinomaAntoine Galmiche, Zakaria Ezzoukhry, Catherine François, et al.
Clinical and Translational Gastroenterology|September 4, 2019
Long-Term Natural History of Microscopic Colitis: A Population-Based CohortJulien Loreau, Dana Duricova, Corinne Gower-Rousseau, et al.
Plos One|December 31, 2013
Identification of SLAMF3 (CD229) as an inhibitor of hepatocellular carcinoma cell proliferation and tumour progressionIngrid Marcq, Rémy Nyga, Flora Cartier, et al.
The Lancet. Gastroenterology & Hepatology|July 10, 2018
Non-invasive diagnosis of liver fibrosis in patients with alcohol-related liver disease by transient elastography: an individual patient data meta-analysisEric Nguyen-Khac, Maja Thiele, Cosmin Voican, et al.
Cell Biology and Toxicology|February 26, 2026
Chronic cadmium exposure promotes TRPM7-dependent acquisition of a myofibroblast-like phenotype in pancreatic stellate cellsMathilde Fourgeaud, Julie Auwercx, Alexis Lalot, et al.
Endocrine-Related Cancer|August 3, 2022
Second-line treatment and prognostic factors in neuroendocrine carcinoma: the RBNEC studyJulien Hadoux, Thomas Walter, Christina Kanaan, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2021
Prognostic factors of metastatic neuroendocrine carcinoma under first-line treatment with platinum etoposide with a focus on NEC score and Rb expression: Results from the multicentre RBNEC study of the Groupe d'Etude des Tumeurs Endocrines (GTE) and the ENDOCAN-RENATEN networkJulien Hadoux, Christina Kanaan, Alice Durand, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 4, 2014
Tumour size over 3 cm predicts poor short-term outcomes after major liver resection for hilar cholangiocarcinoma. By the HC-AFC-2009 groupJean Marc Regimbeau, David Fuks, Patrick Pessaux, et al.
Pageof 14